Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors-Reference-Cited by-同舟云学术

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors

Published:2023-09 Issue: Volume:30 Page:103-116
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Béguin Jérémy,Laloy Eve,Cochin Sandrine,Gantzer Murielle,Farine Isabelle,Pichon Christelle,Moreau Baptiste,Foloppe Johann,Balloul Jean-Marc,Machon Christelle,Guitton Jérôme,Tierny Dominique,Klonjkowski Bernard,Quéméneur Eric,Maurey Christelle,Erbs Philippe^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference52 articles.

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma;Andtbacka;J. Clin. Oncol.,2015

2. The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism;Foloppe;Mol. Ther. Oncolytics,2019

3. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus;Foloppe;Gene Ther.,2008

4. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene;Erbs;Cancer Res.,2000

5. Preclinical evaluation of the oncolytic vaccinia virus TG6002 by translational research on canine breast cancer;Béguin;Mol. Ther. Oncolytics,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade;Veterinary and Comparative Oncology;2024-08-23

2. A Review on Canine and Human Soft Tissue Sarcomas: New Insights on Prognosis Factors and Treatment Measures;Veterinary Sciences;2024-08-10

3. A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer;2024-07-31

4. The role of viruses in cancer progression versus cancer treatment: A dual paradigm;Life Sciences;2024-03

5. Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma;International Journal of Molecular Sciences;2024-02-07